A numerical example from the pharmaceutical industry

The system dynamics-based model and the extrapolation framework were developed within a research project conducted at the Chair of Logistics Management of the University of St.Gallon in the years 2008 and 2009. Ten companies from the Swiss pharmaceutical and consumer goods industry were involved in the research project. Through this cooperation, data for the nmnerical example was gathered to test and improve the quantification approach stepwise. 

6 Determination of an SCFs effect on costs and capital commitment 

The raw material sourced from company SCi is segmented into carton with standard formats which is either stored at call at SCi s suppliers or at company 

SCi as well as customer specific formats Rf ). The folding boxes are 

Tolerance in order quantity Tolerance in order fr-equency Saftey stock level of Allocation of 

---

There are numerous automatic titrators that employ potentiometric end-point detection. They usually can automatically record the first or second derivative of the titration curve and read out the end-point volume. The sample is placed in the titration vessel, and the titrant, drawn from a reservoir, is placed in a syringe-driven buret. The volume is digitally read from the displacement of the syringe plunger by the electronic driver. Titrators may also employ photometric detection of indicator color changes. An automatic titrator is shown in Figure 14.7. Automatic titrators make volumetric analyses rapid, reproducible, and convenient. While instrumental methods provide many advantages, classical volumetric analyses are still widely used and are very useful, especially for major constituents, for example, in the pharmaceutical industry. 

There are numerous examples of enantioselective reductions employing the CBS catalyst from both academic and industrial laboratories that attest to the generality and robustness of the process [114, 120]. Corey showcased its use in an enantioselective synthesis of ginkgolide B (201), a potent antagonist of the platelet activating factor (Scheme 2.24) [135]. Treatment of 199 with catalyst 187 and BH3-THF as the stoichiometric reductant furnishes alcohol 200 in 88% yield and 93% ee. A recent application of its use drawn from the pharmaceutical industry is the synthesis of ezetimibe (204), the first drug approved for inhibition of intestinal cholesterol absorption (Scheme 2.25) [136]. 

Ratio measurements in analytical chemistry will often relate values in different units for the numerator and denominator. The most commonly used ratios between SI units are summarized in matrix form in Table 1 (adapted from [5]). Confusion may result when values are stated in different SI quantities. The pharmaceutical industry, for example, is careful to distinguish values in mg/g from values in mmol/g. It is important to retain the two units used in expressing a ratio such as mol/g. Differential measurements are often made, obtaining a ratio of ratios for which the numerator and denominator are generally expressed in multiples of identical pairs of units, e.g. (g/L)/(g/L). For such a ratio of ratios no great harm is done by stating, for instance the con-... 

As another example of someone familiar to me from my work as a product liability expert, Jan Fawcett has conducted numerous clinical trials for drug companies over the years. He lists himself as a consultant to ten pharmaceutical companies, as a Speaker s Bureau member for eight pharmaceutical companies, and as recipient of grants and research support from eight pharmaceutical companies. Curiously, Fawcett lists a ninth institution, the NIMH, under industry affiliations, confirming my view that NIMH is now a part of the psychopharmaceutical complex and might as well be considered a branch of the pharmaceutical industry. 

The various approaches to forming heterocyclic ring systems by intramolecular cyclizations were discussed in Chapter 4 and by cycloaddition reactions in Chapter 5. In Chapters 6 and 7, numerous reactions of heterocyclics were described. We will now reexamine some of this material from a different standpoint, taking a particular heterocyclic family and considering some of the methods that are useful for the construction of the family. In addition, some information on the synthesis of important heterocycles not yet considered will be presented. As was discussed in Chapter 8, great numbers of new heterocyclic compounds have been, and continue to be, synthesized in the research laboratories of the pharmaceutical industry in their search for new materials of value in medicine, and the many accomplishments from this work provide a multitude of examples that can be used to illustrate the practical application of heterocycMc chemistry. However, the presentation must be limited to a small number of examples for more in-depth discussions of important syntheses, two works by... 

---